KR890012659A - 조산아의 뇌실내 출혈방지용 치료제 - Google Patents

조산아의 뇌실내 출혈방지용 치료제 Download PDF

Info

Publication number
KR890012659A
KR890012659A KR1019890002127A KR890002127A KR890012659A KR 890012659 A KR890012659 A KR 890012659A KR 1019890002127 A KR1019890002127 A KR 1019890002127A KR 890002127 A KR890002127 A KR 890002127A KR 890012659 A KR890012659 A KR 890012659A
Authority
KR
South Korea
Prior art keywords
premature infants
intraventricular hemorrhage
hemorrhage treatment
treatment
intraventricular
Prior art date
Application number
KR1019890002127A
Other languages
English (en)
Other versions
KR0137476B1 (ko
Inventor
아끼라 시라하따
미노르 우찌다
사또시 다나까
게니찌로 쭈무라
Original Assignee
아다찌 가쭈오
훽스트 제팬 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아다찌 가쭈오, 훽스트 제팬 리미티드 filed Critical 아다찌 가쭈오
Publication of KR890012659A publication Critical patent/KR890012659A/ko
Application granted granted Critical
Publication of KR0137476B1 publication Critical patent/KR0137476B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

내용 없음.

Description

조산아의 뇌실내 출혈방지용 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 조산아의 뇌실내(intraventricular) 출혈 방지용 약제의 제조를 위한 사람의 응고 인자 XIII의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890002127A 1988-02-24 1989-02-23 조산아의뇌실내출혈방지용치료제 KR0137476B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP?63-39646 1988-02-24
JP63-39646 1988-02-24
JP63039646A JPH01216939A (ja) 1988-02-24 1988-02-24 末熟児頭蓋内出血阻止剤

Publications (2)

Publication Number Publication Date
KR890012659A true KR890012659A (ko) 1989-09-18
KR0137476B1 KR0137476B1 (ko) 1998-06-01

Family

ID=12558846

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890002127A KR0137476B1 (ko) 1988-02-24 1989-02-23 조산아의뇌실내출혈방지용치료제

Country Status (12)

Country Link
US (1) US5114916A (ko)
EP (1) EP0330049B1 (ko)
JP (1) JPH01216939A (ko)
KR (1) KR0137476B1 (ko)
AT (1) ATE94070T1 (ko)
AU (1) AU613154B2 (ko)
CA (1) CA1332352C (ko)
DE (1) DE68908913T2 (ko)
DK (1) DK174978B1 (ko)
ES (1) ES2059588T3 (ko)
IE (1) IE63656B1 (ko)
PT (1) PT89802B (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
JPH07502734A (ja) * 1991-12-31 1995-03-23 ザイモジェネティクス，インコーポレイティド 血液損失を減少する方法および組成物
JP3550685B2 (ja) * 1992-04-21 2004-08-04 味の素株式会社 創傷治療剤
ATE184199T1 (de) * 1992-11-12 1999-09-15 Zymogenetics Inc Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen
JPH07328108A (ja) * 1994-06-10 1995-12-19 Ajinomoto Co Inc 生体組織接着剤及び血液凝固剤
EP2158923B1 (en) 1998-08-06 2013-02-27 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
US20080176789A1 (en) * 2004-08-27 2008-07-24 Novc Nordisk Healthcare A/G Purification of Factor Xlll Polypeptides From Biological Materials
CA2587139C (en) * 2004-11-23 2014-05-27 Zymogenetics, Inc. Purification of recombinant human factor xiii
PL3321359T3 (pl) 2005-04-11 2021-06-28 Horizon Pharma Rheumatology Llc Wariantowe postacie oksydazy moczanowej i ich zastosowanie
TWI418564B (zh) * 2005-04-11 2013-12-11 Savient Pharmaceuticals Inc 利用陽離子界面活性劑之蛋白質純化
ES2532804T3 (es) * 2006-04-12 2015-03-31 Crealta Pharmaceuticals Llc Purificación de proteínas con tensioactivo catiónico
KR101861547B1 (ko) 2009-06-25 2018-07-02 크레알타 파마슈티칼스 엘엘씨 페길화된 유리카아제 치료 중에 혈청 요산을 모니터링하여 주입 반응의 위험성 및 반응의 항체­매개 상실을 예측하는 방법 및 키트

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717708A (en) * 1968-10-24 1973-02-20 Cutter Lab Blood coagulation complex
DE2063070C3 (de) * 1970-12-22 1975-07-24 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Arzneimittels mit fibrinstabilisierender Wirkung
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
ATE121776T1 (de) * 1986-09-19 1995-05-15 Zymogenetics Inc Expression des biologisch aktiven faktors xiii.

Also Published As

Publication number Publication date
AU3024389A (en) 1989-08-24
DK83889D0 (da) 1989-02-23
DE68908913T2 (de) 1994-01-27
JPH01216939A (ja) 1989-08-30
AU613154B2 (en) 1991-07-25
IE63656B1 (en) 1995-05-31
ES2059588T3 (es) 1994-11-16
PT89802A (pt) 1989-10-04
ATE94070T1 (de) 1993-09-15
EP0330049A3 (en) 1991-01-30
DE68908913D1 (de) 1993-10-14
DK174978B1 (da) 2004-04-05
DK83889A (da) 1989-08-25
IE890580L (en) 1989-08-24
EP0330049B1 (en) 1993-09-08
CA1332352C (en) 1994-10-11
KR0137476B1 (ko) 1998-06-01
JPH0378850B2 (ko) 1991-12-17
PT89802B (pt) 1994-04-29
EP0330049A2 (en) 1989-08-30
US5114916A (en) 1992-05-19

Similar Documents

Publication Publication Date Title
KR890011606A (ko) 항응고제
KR890000101A (ko) 반월조직의 치료 개선방법 및 치료약제
DE3872372D1 (de) Zusammensetzung zur erhoehung der intrazell-atp-spiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.
KR920019342A (ko) 골질환 치료제
NO951592D0 (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system
DE3587941D1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
DK642587D0 (da) Insulinpraeparat
KR890012659A (ko) 조산아의 뇌실내 출혈방지용 치료제
KR920017655A (ko) 상처의 치료를 촉진시키기 위한 약학 조성물
KR890015742A (ko) 이병치료용 국소 제제
KR970025615A (ko) 암 전이 억제제
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
KR880009661A (ko) 궤양성 대장염치료를 위한 사람의 혈액응고인자 xiii의 용도
DE59003020D1 (de) Piroxicam enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung.
KR890003374A (ko) 정신 분열증 치료용 약제의 제조에 2-아미노-6-(트리플루오로메톡시)벤조티아졸의 이용
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
KR930019224A (ko) 유산 위험 치료제
ATE124627T1 (de) Diclofenac-natrium enthaltende pharmazeutische zusammensetzung zur topischen anwendung.
KR910021244A (ko) 당뇨병성 괴저 치료제
KR960701657A (ko) 피부 상처 치료용 인자 XIII (Factor XIII for treatment of skin wounds)
KR880000094A (ko) 위염치료제
KR910015294A (ko) 약제 조성물
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
KR900017592A (ko) Tnf의 부작용을 감소시키기 위한 용도 및 약제

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120202

Year of fee payment: 15

EXPY Expiration of term